vs
Guardian Pharmacy Services, Inc.（GRDN）与奥驰亚（MO）财务数据对比。点击上方公司名可切换其他公司
奥驰亚的季度营收约是Guardian Pharmacy Services, Inc.的14.7倍（$5.8B vs $397.6M）。奥驰亚净利率更高（19.1% vs 5.3%，领先13.8%）
CVS药房是美国零售企业，为CVS健康旗下子公司，总部位于罗德岛州文索基特，前身为Consumer Value Stores，1963年在马萨诸塞州洛厄尔成立，是美国知名的零售药房服务提供商，在药品零售、健康服务领域拥有广泛的业务布局。
奥驰亚集团是美国头部烟草企业，通过旗下子公司生产销售可燃烟草与口服类烟草相关产品，核心品牌包括万宝路香烟、Black & Mild雪茄及烟斗烟、哥本哈根、斯库尔等湿无烟烟草，以及on!口服尼古丁袋，产品主要供应批发商、分销商及大型零售客户。
GRDN vs MO — 直观对比
营收规模更大
MO
是对方的14.7倍
$397.6M
净利率更高
MO
高出13.8%
5.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $397.6M | $5.8B |
| 净利润 | $20.9M | $1.1B |
| 毛利率 | 21.5% | 62.1% |
| 营业利润率 | 7.7% | 28.2% |
| 净利率 | 5.3% | 19.1% |
| 营收同比 | — | -2.1% |
| 净利润同比 | — | -63.2% |
| 每股收益（稀释后） | — | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GRDNMO
| Q4 25 | $397.6M | $5.8B | ||
| Q3 25 | $377.4M | $6.1B | ||
| Q2 25 | $344.3M | $6.1B | ||
| Q1 25 | $329.3M | $5.3B | ||
| Q4 24 | — | $6.0B | ||
| Q3 24 | $314.4M | $6.3B | ||
| Q2 24 | — | $6.2B | ||
| Q1 24 | — | $5.6B |
净利润GRDNMO
| Q4 25 | $20.9M | $1.1B | ||
| Q3 25 | $9.8M | $2.4B | ||
| Q2 25 | $9.0M | $2.4B | ||
| Q1 25 | $9.4M | $1.1B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | $-122.0M | $2.3B | ||
| Q2 24 | — | $3.8B | ||
| Q1 24 | — | $2.1B |
毛利率GRDNMO
| Q4 25 | 21.5% | 62.1% | ||
| Q3 25 | 19.8% | 62.8% | ||
| Q2 25 | 19.8% | 63.1% | ||
| Q1 25 | 19.5% | 61.8% | ||
| Q4 24 | — | 60.3% | ||
| Q3 24 | 19.4% | 60.8% | ||
| Q2 24 | — | 59.2% | ||
| Q1 24 | — | 58.8% |
营业利润率GRDNMO
| Q4 25 | 7.7% | 28.2% | ||
| Q3 25 | 4.3% | 53.2% | ||
| Q2 25 | 3.7% | 52.9% | ||
| Q1 25 | 3.9% | 34.0% | ||
| Q4 24 | — | 48.2% | ||
| Q3 24 | -33.3% | 50.4% | ||
| Q2 24 | — | 40.8% | ||
| Q1 24 | — | 48.0% |
净利率GRDNMO
| Q4 25 | 5.3% | 19.1% | ||
| Q3 25 | 2.6% | 39.1% | ||
| Q2 25 | 2.6% | 39.0% | ||
| Q1 25 | 2.9% | 20.5% | ||
| Q4 24 | — | 50.9% | ||
| Q3 24 | -38.8% | 36.6% | ||
| Q2 24 | — | 61.2% | ||
| Q1 24 | — | 38.2% |
每股收益（稀释后）GRDNMO
| Q4 25 | — | $0.67 | ||
| Q3 25 | — | $1.41 | ||
| Q2 25 | — | $1.41 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $1.78 | ||
| Q3 24 | — | $1.34 | ||
| Q2 24 | — | $2.21 | ||
| Q1 24 | — | $1.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $65.6M | $4.5B |
| 总债务越低越好 | $0 | $25.7B |
| 股东权益账面价值 | $217.9M | $-3.5B |
| 总资产 | $412.7M | $35.0B |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资GRDNMO
| Q4 25 | $65.6M | $4.5B | ||
| Q3 25 | $36.5M | $3.5B | ||
| Q2 25 | $18.8M | $1.3B | ||
| Q1 25 | $14.0M | $4.7B | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | $37.2M | $1.9B | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $3.6B |
总债务GRDNMO
| Q4 25 | $0 | $25.7B | ||
| Q3 25 | — | $25.7B | ||
| Q2 25 | — | $24.7B | ||
| Q1 25 | — | $26.1B | ||
| Q4 24 | — | $24.9B | ||
| Q3 24 | $34.3M | $25.2B | ||
| Q2 24 | — | $25.0B | ||
| Q1 24 | — | $25.0B |
股东权益GRDNMO
| Q4 25 | $217.9M | $-3.5B | ||
| Q3 25 | $195.5M | $-2.6B | ||
| Q2 25 | $179.7M | $-3.3B | ||
| Q1 25 | $163.2M | $-3.5B | ||
| Q4 24 | — | $-2.2B | ||
| Q3 24 | $133.9M | $-3.5B | ||
| Q2 24 | — | $-3.0B | ||
| Q1 24 | — | $-5.1B |
总资产GRDNMO
| Q4 25 | $412.7M | $35.0B | ||
| Q3 25 | $390.0M | $35.0B | ||
| Q2 25 | $356.3M | $32.3B | ||
| Q1 25 | $334.0M | $35.8B | ||
| Q4 24 | — | $35.2B | ||
| Q3 24 | $348.0M | $34.2B | ||
| Q2 24 | — | $34.4B | ||
| Q1 24 | — | $36.5B |
负债/权益比GRDNMO
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $34.6M | $3.3B |
| 自由现金流经营现金流 - 资本支出 | — | $3.2B |
| 自由现金流率自由现金流/营收 | — | 54.4% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | 1.65× | 2.93× |
| 过去12个月自由现金流最近4个季度 | — | $9.1B |
8季度趋势，按日历期对齐
经营现金流GRDNMO
| Q4 25 | $34.6M | $3.3B | ||
| Q3 25 | $28.2M | $3.1B | ||
| Q2 25 | $19.9M | $205.0M | ||
| Q1 25 | $17.6M | $2.7B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | — | $-75.0M | ||
| Q1 24 | — | $2.9B |
自由现金流GRDNMO
| Q4 25 | — | $3.2B | ||
| Q3 25 | $24.2M | $3.0B | ||
| Q2 25 | — | $173.0M | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | — | $-104.0M | ||
| Q1 24 | — | $2.8B |
自由现金流率GRDNMO
| Q4 25 | — | 54.4% | ||
| Q3 25 | 6.4% | 50.1% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 51.0% | ||
| Q4 24 | — | 55.1% | ||
| Q3 24 | — | 41.2% | ||
| Q2 24 | — | -1.7% | ||
| Q1 24 | — | 51.0% |
资本支出强度GRDNMO
| Q4 25 | — | 1.6% | ||
| Q3 25 | 1.1% | 0.9% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.6% |
现金转化率GRDNMO
| Q4 25 | 1.65× | 2.93× | ||
| Q3 25 | 2.87× | 1.30× | ||
| Q2 25 | 2.21× | 0.09× | ||
| Q1 25 | 1.86× | 2.53× | ||
| Q4 24 | — | 1.10× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | -0.02× | ||
| Q1 24 | — | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GRDN
暂无分部数据
MO
| Smokeable Products Segment | $5.1B | 88% |
| Oral Tobacco Segment | $706.0M | 12% |
